Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 15Endocrine 15Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 23Myeloproliferative Disorders 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Polycythemia Vera 10Primary Myelofibrosis 7Thrombocythemia, Essential 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia 4Polycythemia 3Lymphohistiocytosis, Hemophagocytic 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Hematologic Diseases 3Recurrence 2Myelodysplastic-Myeloproliferative Diseases 2Motor Activity 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma 2Epstein-Barr Virus Infections 2VEXAS syndrome 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thrombophilia 1Thrombocytosis 1Thrombocytopenia 1Polycythemia, primary familial and congenital 1Pleural Effusion, Malignant 1

Interventions

trametinib 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroid Cancer, Papillary × Myeloid × Clear all
NCT07440290 2026-02-27

DETERMINE

Cancer Research UK

Phase 2/3 Not yet recruiting
30 enrolled
CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡